Literature DB >> 24477948

Management of craniopharyngiomas.

N Karavitaki.   

Abstract

Craniopharyngiomas are rare epithelial tumours arising along the path of the craniopharyngeal duct. Their pathogenesis remains uncertain and they can present with a variety of manifestations attributed to pressure effects to surrounding structures. The optimal management of craniopharyngiomas remains challenging mainly due to their sharp, irregular borders and their tendency to adhere to vital neurovascular structures making surgical manipulations potentially hazardous to vital brain areas. Non-aggressive surgery followed by radiotherapy is currently the most widely used option possibly achieving the most optimal long-term outcome. Other treatment modalities including intracystic irradiation, intracystic instillation of antineoplasmatic agents and stereotactic radiotherapy are also available in our armamentarium. The long-term morbidities related with the craniopharyngiomas and their treatment remain significant, with hypothalamic damage playing the protagonist role and requiring further studies to identify measures that will improve the prognosis of the patients.

Entities:  

Mesh:

Year:  2014        PMID: 24477948     DOI: 10.1007/s40618-013-0050-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  74 in total

1.  MR differentiation of adamantinous and squamous-papillary craniopharyngiomas.

Authors:  S Sartoretti-Schefer; W Wichmann; A Aguzzi; A Valavanis
Journal:  AJNR Am J Neuroradiol       Date:  1997-01       Impact factor: 3.825

2.  Evaluation of postoperative intratumoral injection of bleomycin for craniopharyngioma in children.

Authors:  H Takahashi; S Nakazawa; T Shimura
Journal:  J Neurosurg       Date:  1985-01       Impact factor: 5.115

3.  GH replacement does not increase the risk of recurrence in patients with craniopharyngioma.

Authors:  Niki Karavitaki; Justin T Warner; Anne Marland; Brian Shine; Fiona Ryan; Jayanth Arnold; Helen E Turner; John A H Wass
Journal:  Clin Endocrinol (Oxf)       Date:  2006-05       Impact factor: 3.478

4.  Efficacy and safety of growth hormone treatment in children with prior craniopharyngioma: an analysis of the Pharmacia and Upjohn International Growth Database (KIGS) from 1988 to 1996.

Authors:  D A Price; P Wilton; P Jönsson; K Albertsson-Wikland; P Chatelain; W Cutfield; M B Ranke
Journal:  Horm Res       Date:  1998

5.  Obesity in childhood craniopharyngioma: relation to post-operative hypothalamic damage shown by magnetic resonance imaging.

Authors:  C J de Vile; D B Grant; R D Hayward; B E Kendall; B G Neville; R Stanhope
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

6.  Cystic craniopharyngioma: long-term results after intracavitary irradiation with stereotactically applied colloidal beta-emitting radioactive sources.

Authors:  J Voges; V Sturm; R Lehrke; H Treuer; C Gauss; F Berthold
Journal:  Neurosurgery       Date:  1997-02       Impact factor: 4.654

7.  Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011.

Authors:  Michal Cohen; Ute Bartels; Helen Branson; Abhaya V Kulkarni; Jill Hamilton
Journal:  Neuro Oncol       Date:  2013-03-13       Impact factor: 12.300

Review 8.  Craniopharyngiomas.

Authors:  Niki Karavitaki; Simon Cudlip; Christopher B T Adams; John A H Wass
Journal:  Endocr Rev       Date:  2006-03-16       Impact factor: 19.871

9.  Replacement of growth hormone (GH) in normally growing GH-deficient patients operated for craniopharyngioma.

Authors:  E J Schoenle; J Zapf; A Prader; T Torresani; E A Werder; M Zachmann
Journal:  J Clin Endocrinol Metab       Date:  1995-02       Impact factor: 5.958

10.  Learning and memory following conformal radiation therapy for pediatric craniopharyngioma and low-grade glioma.

Authors:  Marcos Di Pinto; Heather M Conklin; Chenghong Li; Thomas E Merchant
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-08-04       Impact factor: 7.038

View more
  10 in total

Review 1.  Risk-adapted, long-term management in childhood-onset craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

2.  Visceral adiposity index as an indicator of cardiometabolic risk in patients treated for craniopharyngioma.

Authors:  Francesco Ferraù; Federica Spagnolo; Oana Ruxandra Cotta; Laura Cannavò; Angela Alibrandi; Giuseppina Tiziana Russo; Tommaso Aversa; Francesco Trimarchi; Salvatore Cannavò
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

Review 3.  Brachytherapy in paediatric craniopharyngiomas: a systematic review and meta-analysis of recent literature.

Authors:  M Mazzuia Guimarães; D Dante Cardeal; M Jacobsen Teixeira; J Erasmo Dal Col Lucio; F Hada Sanders; R Kei Kuromoto; H Matushita
Journal:  Childs Nerv Syst       Date:  2021-10-07       Impact factor: 1.475

Review 4.  Microsurgical removal of craniopharyngioma: endoscopic and transcranial techniques for complication avoidance.

Authors:  Saira Alli; Semra Isik; James T Rutka
Journal:  J Neurooncol       Date:  2016-05-19       Impact factor: 4.130

5.  An endoscopic endonasal approach to craniopharyngioma via the infrachiasmatic corridor: a single center experience of 84 patients.

Authors:  Savas Ceylan; Melih Caklili; Atakan Emengen; Eren Yilmaz; Yonca Anik; Alev Selek; Filiz Cizmecioglu; Burak Cabuk; Ihsan Anik
Journal:  Acta Neurochir (Wien)       Date:  2021-04-08       Impact factor: 2.816

Review 6.  Recent advances in molecular pathology of craniopharyngioma.

Authors:  Sarah Larkin; Niki Karavitaki
Journal:  F1000Res       Date:  2017-07-24

Review 7.  Endocrine Disorder in Patients With Craniopharyngioma.

Authors:  Zihao Zhou; Sheng Zhang; Fangqi Hu
Journal:  Front Neurol       Date:  2021-12-02       Impact factor: 4.003

8.  Clinical Outcomes of Transcranial and Endoscopic Endonasal Surgery for Craniopharyngiomas: A Single-Institution Experience.

Authors:  Chuansheng Nie; Youfan Ye; Jingnan Wu; Hongyang Zhao; Xiaobing Jiang; Haijun Wang
Journal:  Front Oncol       Date:  2022-02-10       Impact factor: 6.244

Review 9.  Craniopharyngioma and hypothalamic injury: latest insights into consequent eating disorders and obesity.

Authors:  Hermann L Müller
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2016-02       Impact factor: 3.243

Review 10.  The Role of Surgical Approaches in the Multi-Modal Management of Adult Craniopharyngiomas.

Authors:  Christopher S Hong; Sacit Bulent Omay
Journal:  Curr Oncol       Date:  2022-02-24       Impact factor: 3.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.